Kiener Peter A
- SEC CIK
- 0001328146
No open-market purchases or sales filed in the past year.
Current role at each company
- CUE Cue Biopharma, Inc.Directoras of Jan 6, 2026
- LVTX LAVA Therapeutics NVDirectoras of Nov 17, 2025
- PVLA Palvella Therapeutics, Inc.Directoras of Jun 23, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Kiener Peter A as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CUE Cue Biopharma, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2021 (view filing) | Nov 15-16 | 2 days | Kiener Peter ADirector | SSale | −20.2K | $17.93 | −$361.7K | −100.0%0 after | 2 lots |
| Mar 27, 2023 (view filing) | Mar 23 | 4 days | Kiener Peter ADirector | SSale | −9.32K | $3.28 | −$30.6K | −96.3%357 after |